FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

C&T Dream Co. CGMP Violations

FDA warns South Koreas C&T Dream Co. about CGMP violations in its manufacturing of finished drugs.

latest-news-card-1
Medical Devices

New CDRH Dataset for Chemical Characterization

FDA launches a new public dataset to help chemistry labs ensure the robustness of chemical characterization methods used to assess the biocompatibilit...

latest-news-card-1
Biologics

GSK BLA Accepted for Meningococcal Vaccine

FDA accepts for review a GSK BLA for its 5-in-1 meningococcal ABCWY vaccine candidate.

latest-news-card-1
Medical Devices

Soulaire Marketing Unapproved Device: FDA

FDA warns Soulaire Corp. that it is marketing an external counterpulsation system for unapproved uses, adulterating and misbranding the unit.

latest-news-card-1
Human Drugs

2 CGMP Violations in Natco Pharma Inspection

FDA warns the Telangana, India-based Natco Pharma manufacturing facility about CGMP violations in its production of finished drugs.

latest-news-card-1
Federal Register

Clinical Trial Innovation Center Established

CDER establishes the Center for Clinical Trial Innovation to support innovative approaches to clinical trials that are designed to improve the quality...

latest-news-card-1
Medical Devices

Ex-CEO Sentenced Over Phony Covid Test

A federal court sentences former Decision Diagnostics CEO Keith Berman to seven years in prison for a securities fraud scheme involving a Covid-detect...

latest-news-card-1
Human Drugs

Novartis Reports Favorable Data on Kidney Drug

Novartis reports favorable data from a pre-specified interim analysis of the Phase 3 APPLAUSE-IgAN study of early kidney failure indirect surrogate ma...

Medical Devices

FDA Clears 3D Printed Cranial Implant

FDA clears a 3D Systems 510(k) for its 3D-printed, patient-specific cranial implant VSP PEEK Cranial Implant and its use in restoring skull defects.

latest-news-card-1
Human Drugs

FDA Inspection Hits Zydus With Form-483

FDA issues Zydus Lifesciences a four-item Form FDA-483 after inspecting the firms manufacturing facility (Matoda, Gujarat, India).